Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019063581) NEW THERAPY FOR OSTEOARTHRITIC PAIN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/063581 International Application No.: PCT/EP2018/076049
Publication Date: 04.04.2019 International Filing Date: 26.09.2018
IPC:
A61K 33/14 (2006.01) ,A61K 33/42 (2006.01) ,A61P 19/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
14
Alkali metal chlorides; Alkaline earth metal chlorides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
42
Phosphorus; Compounds thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19
Drugs for skeletal disorders
02
for joint disorders, e.g. arthritis, arthrosis
Applicants:
MERCK PATENT GMBH [DE/DE]; Frankfurter Strasse 250 64293 Darmstadt, DE
Inventors:
LADEL, Christoph H.; DE
GUEHRING, Hans; DE
Agent:
MERCK SERONO S.A.; Terre Bonne Business Park A2 Route de Crassier 15 1262 Eysins, CH
Priority Data:
17193587.727.09.2017EP
Title (EN) NEW THERAPY FOR OSTEOARTHRITIC PAIN
(FR) NOUVELLE THÉRAPIE DE LA DOULEUR OSTÉOARTHRITIQUE
Abstract:
(EN) The present invention relates to the treatment of osteoarthritic pain and to the slowing down of the structural osteoarthritis progression in a patient having osteoarthritis. More particularly, it relates to a physiological compound for use according to particular treatment regimens. Specifically, it concerns a treatment scheme comprising weekly administration for three or four times of a physiological compound per treatment cycle.
(FR) La présente invention concerne le traitement de la douleur ostéoarthritique et le ralentissement de l'évolution de l'arthrose structurale chez un patient souffrant d'arthrose. Plus particulièrement, l'invention concerne un composé physiologique destiné à être utilisé selon des régimes de traitement particuliers. Spécifiquement, elle concerne un schéma de traitement comprenant une administration hebdomadaire trois ou quatre fois d'un composé physiologique par cycle de traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)